Skip to Content

Drug interactions between bictegravir / emtricitabine / tenofovir alafenamide and Escavite

Results for the following 2 drugs:
bictegravir/emtricitabine/tenofovir alafenamide
Escavite (multivitamin with iron and fluoride)

Interactions between your drugs

Major

multivitamin with iron and fluoride bictegravir

Applies to: Escavite (multivitamin with iron and fluoride) and bictegravir / emtricitabine / tenofovir alafenamide

Products that contain aluminum, calcium, iron, magnesium or other minerals such as antacids and supplements may interfere with the absorption of bictegravir and reduce its effectiveness in treating HIV infection. Additionally, it may lead to development of viral resistance to this and various other HIV medications that are currently used for treatment. When used with antacids, you should generally take bictegravir on an empty stomach at least two hours before the antacid. Avoid taking bictegravir simultaneously with, or 2 hours after, antacid dosing whenever possible. When used with multivitamin or mineral supplements, you may take bictegravir and supplements together at the same time, but with food. Avoid taking bictegravir on an empty stomach simultaneously with, or 2 hours after, dosing of supplements. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed, or if you have trouble separating the dosing times. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Minor

multivitamin with iron and fluoride food

Applies to: Escavite (multivitamin with iron and fluoride)

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

For clinical details see professional interaction data.

Minor

tenofovir food

Applies to: bictegravir / emtricitabine / tenofovir alafenamide

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

For clinical details see professional interaction data.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide